Ticker

Analyst Price Targets — OPK

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
October 30, 2025 8:10 pmJefferies$1.60$1.46TheFly Opko Health downgraded to Hold from Buy at Jefferies
September 17, 2024 6:52 amYi ChenH.C. Wainwright$3.00$1.70StreetInsider H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
December 15, 2022 6:56 amH.C. Wainwright$3.00$1.29Benzinga HC Wainwright & Co. Initiates Coverage On OPKO Health with Buy Rating, Announces Price Target of $3
August 4, 2022 8:38 pmEdward TenthoffPiper Sandler$4.00$2.40TheFly Opko Health price target lowered to $4 from $5 at Piper Sandler

Latest News for OPK

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th.

GlobeNewsWire • Feb 27, 2026
Critical Analysis: OPKO Health (NASDAQ:OPK) vs. Sintx Technologies (NASDAQ:SINT)

OPKO Health (NASDAQ: OPK - Get Free Report) and Sintx Technologies (NASDAQ: SINT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This is a summary of

Defense World • Feb 27, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for OPK.

No House trades found for OPK.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top